Mechanisms of Improvement of Erythropoiesis with Low Dose of Deferasirox in Low Risk Myelodysplastic Syndromes. (April 2017) - Meunier, M.; Ancelet, S.; Lefebvre, C.; Arnaud, J.; Garrel, C.; Wang, Y.; Faure, P.; Moulis, J.M.; Polack, B.; Cahn, J.Y.; Park, S.